Skip to main content

Investor Relations

Breaking Through the Blood-Brain Barrier

Cognos' Mission for Improved Healthcare

Cognos Therapeutics is innovating healthcare with SINNAIS™, an implantable smart pump uniting a programmable pump, intraventricular catheter, and wireless communication. Primarily targeting Alzheimer’s disease, which carries an economic burden of $340 billion annually in the U.S., SINNAIS™ effectively bypasses the blood-brain barrier. It also addresses central nervous system (CNS) diseases such as Leptomeningeal Carcinomatosis (LC), pancreatic cancer, and glioblastoma. The combined treatment market for these CNS-related cancers is approximately $15.8 billion annually, including $6 billion for LC, $8 billion for pancreatic cancer, and $1.8 billion for glioblastoma. With SINNAIS™, Cognos addresses critical treatment gaps, underscoring its potential in Alzheimer’s and these challenging cancer treatments.

Investor Presentation

Latest Investor Presentation

2024 Investor Presentation

Download investor presentation

Press Releases

Sign up for Email Alerts

Stay connected and get the latest company news delivered to your inbox.

Stock Information

NASDAQ: COGN

Cognos Therapeutics, Inc.

Price

Change

Volume

Day Range

52-week Range

Our Leadership Team

The Board of Directors at Cognos Therapeutics Inc., comprising leaders in business, medical research, and scientific technology, is instrumental in safeguarding the company's financial interests. They uphold their fiduciary duty to Investors by setting strategic policies that drive the company’s objectives forward.

Meet our leadership team

Contacts

Corporate Headquarters

Cognos Therapeutics, Inc.
10604 S La Cienega Blvd.
Inglewood, CA 90304
310.641.2700
info@cognosthx.com

Investor Relations

Gilmartin Group
San Francisco
60 E Sir Francis Drake Blvd, Suite 208
Larkspur, CA 94939
info@gilmartinir.com

Transfer Agent

Continental Stock Transfer and Trust
1 State Street, 30th Floor
New York, NY 10004-1561
212.509.4000
cstmail@continentalstock.com